The higher gene expression of ERCC1, ERCC2, and ERCC5 in tumor samples compared to healthy control is consistent with previous studies that reported high tumor tissue levels of NER pathways genes, mainly ERCC1, in SCLC and in other solid tumors [14,15,24,25]. This evidence concerns the gene ERCC2 and small cell lung carcinoma.